Clinical Trial Update: Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nanoparticles with hypofractionated proton therapy for reirradiation of Pantumor relapse has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Recurrent Cancer, Previous Radiation | Phase 2 | Status: WITHDRAWN